1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Analytical Tool - Angiogenesis in Oncology

"Analytical Tool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others
Angiogenesis in Oncology: Drug Pipeline Update 2014*

The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies active in anti-angiogenic R&D in oncology
* Information on key industry related anti-angiogenic drug projects in oncology
* Data from most important clinical trials
* Information on early developmental stage projects
* Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners & competitors
* Laying down a comprehensive framework for further analysis of the field
* Producing presentations surrounding the development of anti-angiogenic drugs in oncology
* Identifying emerging anti-angiogenic cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of anti-angiogenic drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker Group's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Angiogenesis in Oncology

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Superconductors - Global Market Outlook (2016-2022)

Superconductors - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • January 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Superconductor market is accounted for $0.82 billion in 2015 and is expected to reach $2.71 billion by 2022 growing at a compound annual growth rate (CAGR) of 18.6%. ...

Full Body Scanners - Global Market Outlook (2016-2022)

Full Body Scanners - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • January 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Full Body Scanners market is accounted for $0.68 billion in 2015 and expected to reach $7.82 billion by 2022 growing at a CAGR of 41.7% from 2015 to 2022. Huge ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.